AMBER GOTTMAN: Open Payments
NPI 1831589944 · PALMYRA, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$907 in 53 payments from 18 companies in 2025. Trend: 2023 $266 · 2024 $582 · 2025 $907
Food & beverage: $907
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 19 | $167 |
| AstraZeneca Pharmaceuticals LP | 6 | $148 |
| EMD Serono, Inc. | 2 | $104 |
| Otsuka America Pharmaceutical, Inc. | 3 | $83 |
| Axsome Therapeutics, Inc. | 3 | $48 |
| Novo Nordisk Inc | 3 | $43 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $41 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $37 |
| Amgen Inc. | 2 | $34 |
| Teva Pharmaceuticals USA, Inc. | 1 | $33 |
Products named: VRAYLAR, AIRSUPRA, REXULTI, Auvelity, CAPLYTA, JARDIANCE, BREZTRI, AUSTEDO XR.
Industry payments across MO — which companies pay providers there.
